The Department of Health (DOH) on Wednesday clarified that patients who were already given the anti-malarial drug hydroxychloroquine, in the ongoing Solidarity Trial of the World Health Organization, will still continue to undergo the said treatment scheme, a day after it announced that they will stop using the said drug.
Be the first to comment